Target CCR5 is becoming very popular, we are waiting for BLA, mono and first Leronlimab results for cancers in humans, if all goes smoothly I see CYDY as a prospective target for BO, launching Phase II for colon cancer, and announcing Phase II for NASH if they show good results in the lab show that NP is expecting serious takeover negotiations and he is preparing CYDY for it